FDA OKs Medtronic glucose-monitoring device

01/29/2008 | Forbes

The FDA has granted Medtronic approval to market its CGMS iPRO glucose-monitoring device for diabetics. Doctors evaluate the data from the device, which is fastened to a small sensor under the patient's skin, after three days.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory FDA
Cardinal Health
Columbus, OH
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA